Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
precore/core protein|Core and e antigen|
Integrated sequence
ATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAAAGAATTTGGAGCTACTGTGG| |AGTTACTCTCGTTTTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTATCGGGAAGCCTTAGAGTCTCCTGAGCA
End
187922140/187057413 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/2678369; hsa-mir-1244-1/Downstream/1240079;
Upstream sequence
ctgagacaggagaattgcttgaatctgggaggcggaggttgcagtgagtcaagatcgcaccattgcactccagcctgggcaacagtgcaaggctctgtct
Downstream sequence
ggaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaGGGACAACTAATAAATATAAATACATTCAAGAACTGATTACTTGGAAAACAAAACA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.